Quantification of darunavir (TMC114) in human plasma by high-performance liquid chromatography with ultra-violet detection

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 857, Issue 2, 2007, Pages 327-331

  Goldwirt, Lauriane ^a   Chhun, Stéphanie ^a   Rey, Elisabeth ^a   Launay, Odile ^a,b   Viard, Jean Paul ^a,b   Pons, Gérard ^a   Jullien, Vincent ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b EA   (France)

Author keywords

Darunavir; Liquid chromatography; TMC114; UV detection

Indexed keywords

CHROMATOGRAPHIC SYSTEMS; DARUNAVIR; METHYLCLONAZEPAM; ULTRAPURE WATER MIXTURE;

ACETONITRILE; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PATIENT MONITORING; PLASMA (HUMAN); ULTRAVIOLET DETECTORS;

ENZYME INHIBITION;

ACETONITRILE; DARUNAVIR; METHYLCLONAZEPAM; UNCLASSIFIED DRUG; WATER;

ACCURACY; ARTICLE; CHROMATOGRAPHY; DRUG MONITORING; EVAPORATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PLASMA; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; ULTRAVIOLET RADIATION;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HIV PROTEASE INHIBITORS; HUMANS; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET; SULFONAMIDES;

EID: 34648841112     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.07.024     Document Type: Article

References (15)

1. King N.M., Prabu-Jeyabalan M., Nalivaika E.A., Wigerinck P., de Bethune M.-P., and Schiffer C.A. J. Virol. 78 (2004) 12012
2. Koh Y., Nakata H., Maeda K., Ogata H., Bilcer G., Devasamudram T., Kincaid J.F., Boross P., Wang Y.-F., Tie Y., Volarath P., Gaddis L., Harrison R.W., Weber I.T., Ghosh A.K., and Mitsuya H. Antimicrob. Agents Chemother. 47 (2003) 3123
3. De Meyer S., Azijn H., Surleraux D., Jochmans D., Tahri A., Pauwels R., Wigerinck P., and de Bethune M.-P. Antimicrob. Agents Chemother. 49 (2005) 2314
4. Poveda E., Blanco F., Garcia-Gasco P., Alcolea A., Briz V., and Soriano V. AIDS 20 (2006) 1558
5. Molina J.M., Katlama C., Grinsztejn B., Timerman A., Pedro R., De Meyer S., de Béthune M.P., Vangeneugden T., and Lefebvre E. Proceedings of the XVI International AIDS Conference (2006), Toronto, Canada TUPE 0060
6. Morse G.D., Catanzaro L.M., and Acosta E.P. Lancet Infect. Dis. 6 (2006) 215
7. V. Sekar, S. De Meyer, T. Vangeneugden, E. Lefebvre, M. De Pauw, B. Van Baelen, E. De Paepe, P. Vis, M.P. de Bethune, D. Miralles, R. Hoetelmans, Proceedings of the XVI International AIDS Conference, Toronto Canada, 2006, TUPE 0078.
8. Back D., Sekar V., Lefebvre E., Pauw M.D., Paepe E.D., Vangeneugden T., and Hoetelmans R. 8th Intl Congress on Drug Therapy in HIV (2006), Glasgow, United Kingdom PL 5.1
9. Sekar V., Mariën K., De Pauw M., Vangeneugden T., and Hoetelmans R. Proceedings of the IDSA Conference Infectious Disease Society (2006), Toronto WePe3.3C13
10. Delaugerre C., Peytavin G., Dominguez S., Marcelin A.G., Duvivier C., Gourlain K., Amellal B., Legrand M., Raffi F., Costagliola D., Katlama C., and Calvez V. J Med Virol 77 (2005) 345
11. Bouche M.P., Michielsen L., Piot M., and Timmerman P. Proceedings of the 17th International Mass Spectrometry Conference (2006), Prague TUP-042
12. Shah V.P., Midha K.K., Dighe S., McGilveray I.J., Skelly J.P., Yacobi A., Layloff T., Viswanathan C.T., Cook C.E., McDowall R.D., Pittman K.A., and Spector S. Pharm. Res. 9 (1992) 588
13. Shah V.P., Midha K.K., Findlay J.W.A., Hill H.M., Hulse J.D., McGilveray I.J., McKay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., and Yacobi A. Pharm. Res. 17 (2000) 1551
14. Delaugerre C., Mathez D., Peytavin G., Berthe H., Long K., Galperine T., and de Truchis P. AIDS 21 (2007) 1210
15. Sekar V.J., Lefebvre V.E., De Paepe E., De Marez T., De Pauw M., Parys W., and Hoetelmans R.M.W. Antimicrob. Agents Chemother. (2007) AAC.01203